Daniel Vella Friggieri, Regional CEO of Aspen Pharma’s Middle East, North Africa, and Turkey (MENAT) markets, was awarded the ‘Executive of the Year’ title by the company.
Mr Vella Friggieri joined Aspen Pharma in 2016 as Managing Director of the company’s Middle East and North Africa markets. Three years later, he was promoted to his current role.
“I am humbled and honoured to accept the Aspen Pharma Group Executive of the Year award,” the Regional CEO wrote on social media.
“I dedicate this award to all the MENAT team for their trust and resilience every day,” he continued.
Headquartered in Durban, South Africa, Aspen Pharma is a global speciality and branded pharmaceutical company.
Mr Vella Friggieri has a wealth of experience in local and international pharmaceutical industries.
Before joining Aspen Pharma, he held a lengthy tenure at Actavis (now Allergan). He joined the company as Country Manager for Malta and he steadily worked his way up to Regional Director for the North Africa and Levan regions.
Maria Micallef replaces Sue Vella as non-executive Director at HSBC Bank Malta
She currently also serves the same role at PG plc.
Anthony Coleiro to serve as Chairman of the Executive Board of Global Urban Development Malta
GUD is a worldwide non-profit organisation consisting of more than 700 dynamic urban leaders and experts in 60 countries.
Daniel Borg highlights relevance of ‘island dimension’ in policy-making at INSULEUR General Assembly
The Gozo Business Chamber CEO recently spoke at two events, one locally and another in Gran Canaria, Spain.
Sparkasse Bank Malta – first credit institution in the EU approved as Validation Agent for LEI
The LEI is a code that is required for legal entities to fulfill their regulatory obligations and to participate in ...
